1. Home > Latest Topics >

Question 2: Epidemiological profile of AECB

20 June, 2018

question_2_6


LATEST TOPICS

Navigating antibiotic resistance in community-acquired pneumonia: Insights from Vietnam
29 October, 2024
Optimising antibiotic therapy: Insights on transitioning from intravenous to oral treatment for community-acquired pneumonia
27 September, 2024
Community-acquired pneumonia in Cambodia: Navigating the growing challenge of AMR
30 June, 2024
Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024

RELATED ARTICLES

Standardisation of antimicrobial therapy for bronchiectasis
16 January, 2023
Nontuberculous Mycobacteria (NTM) Diseases: Implementing Standardized Treatment
02 January, 2024
Emergence of Mycoplasma Pneumoniae Pneumonia: Key Considerations in Diagnosis and Medication Strategies
26 January, 2024
To what extent does COVID-19 bacterial co-infection impact clinical outcomes?
22 May, 2023
What is the safety profile of a second COVID-19 mRNA vaccine booster?
22 December, 2022